Explore more publications!

Healthcare Today Bahrain: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Bahrain.

Press releases published on April 21, 2026

Outlook Therapeutics Completes Federal Dispute Resolution (FDR) Meeting with FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
PacBio and Lucid Genomics Announce Compatibility Collaboration to Advance Tertiary Analysis for Long-Read Sequencing
Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026
World’s Fastest HIV Test added to the Together TakeMeHome Program for Free at Home HIV Self-Testing Across the United States
New Bay Area Lyme Foundation Study Shows Common FDA-Cleared Lyme Tests Miss 64-78% of Early Cases, Underscores Urgent Need for Improved Diagnostics
AuX Labs Secures $4M to Commercialize Precision Fermentation Cheese Platform
Lice Clinics of America – Longmont Hosts Annual Easter “Egg Hunt” with Free Lice Checks & Treatments
Akari Therapeutics ASCO Abstract Acceptance Highlights Potential for AKTX-101 ADC to Treat KRAS Mutant Tumors
Twentyeight Health Launches First Nationwide All-in-One Virtual Clinic & Personalized Care for Women
Brain Cancer Canada Marks Brain Cancer Awareness Month in May with National Landmark Lightings, Community Events, New Research Investments, and a Call to Action
NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment
Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
Moleculin Announces Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting
Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Leveraging Expertise amid Evaluation  Evolution
Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™
Milestone Scientific Inc. Completes $2.15 Million Private Placement
Allogene Therapeutics Expands Pivotal Phase 2 ALPHA3 Trial to South Korea and Australia
Celularity Announces Closing of Transaction with NexGel
Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions